JP2001504689A5 - - Google Patents

Download PDF

Info

Publication number
JP2001504689A5
JP2001504689A5 JP1998519754A JP51975498A JP2001504689A5 JP 2001504689 A5 JP2001504689 A5 JP 2001504689A5 JP 1998519754 A JP1998519754 A JP 1998519754A JP 51975498 A JP51975498 A JP 51975498A JP 2001504689 A5 JP2001504689 A5 JP 2001504689A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP1998519754A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001504689A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/020037 external-priority patent/WO1998017810A2/fr
Publication of JP2001504689A publication Critical patent/JP2001504689A/ja
Publication of JP2001504689A5 publication Critical patent/JP2001504689A5/ja
Abandoned legal-status Critical Current

Links

JP51975498A 1996-10-25 1997-10-23 多機能性キメラ造血レセプターアゴニスト Abandoned JP2001504689A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2962996P 1996-10-25 1996-10-25
US60/029,629 1996-10-25
PCT/US1997/020037 WO1998017810A2 (fr) 1996-10-25 1997-10-23 Agonistes recepteurs hematopoietiques chimeriques multifonctionnels

Publications (2)

Publication Number Publication Date
JP2001504689A JP2001504689A (ja) 2001-04-10
JP2001504689A5 true JP2001504689A5 (fr) 2005-05-12

Family

ID=21850035

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51975498A Abandoned JP2001504689A (ja) 1996-10-25 1997-10-23 多機能性キメラ造血レセプターアゴニスト

Country Status (17)

Country Link
EP (1) EP0935663A2 (fr)
JP (1) JP2001504689A (fr)
KR (1) KR100497423B1 (fr)
AR (1) AR010041A1 (fr)
AU (1) AU725547B2 (fr)
BR (1) BR9713668A (fr)
CA (1) CA2268742A1 (fr)
CZ (1) CZ295843B6 (fr)
IL (1) IL129565A0 (fr)
NO (1) NO991948L (fr)
NZ (1) NZ335382A (fr)
PL (1) PL333023A1 (fr)
RO (1) RO120919B1 (fr)
RU (2) RU2245887C2 (fr)
TW (2) TW591035B (fr)
WO (1) WO1998017810A2 (fr)
ZA (1) ZA979607B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5581476A (en) 1993-01-28 1996-12-03 Amgen Inc. Computer-based methods and articles of manufacture for preparing G-CSF analogs
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2284127A1 (fr) * 1997-04-11 1998-10-22 G.D. Searle & Co. Proteines chimeriques contenant le ligand flt3
BR9905867A (pt) * 1998-11-06 2001-01-23 Bio Sidus S A Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula
WO2002101047A1 (fr) * 2001-06-12 2002-12-19 Smithkline Beecham Corporation Procede d'identification de composes modulant les activites du gene 1 de reponse primaire a l'epo, eprg1
AU2002325819B2 (en) 2001-07-11 2008-06-19 Maxygen, Inc. G-CSF Conjugates
WO2005047461A2 (fr) 2003-08-18 2005-05-26 The Regents Of The University Of California Bibliotheques d'affichage de polypeptides et procede de fabrication et d'utilisation de celle-ci
CA2607844C (fr) 2005-06-01 2012-07-10 Maxygen Holdings Ltd. Polypeptides g-csf pegyles et procedes de production correspondants
US7550433B2 (en) * 2005-06-03 2009-06-23 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
EP2535346B1 (fr) 2005-08-31 2017-08-02 The Regents of The University of California Bibliothèques cellulaires de séquences peptidiques (CliPS) et procédés d'utilisation de celles-ci
WO2007098548A1 (fr) * 2006-03-01 2007-09-07 Apollo Life Sciences Limited Molécule et chimères de cette molécule
US8293685B2 (en) 2007-07-26 2012-10-23 The Regents Of The University Of California Methods for enhancing bacterial cell display of proteins and peptides
WO2015069489A1 (fr) 2013-11-06 2015-05-14 Merck Patent Gmbh Biomarqueur prédictif pour thérapie à base de promédicament activé par l'hypoxie
CA3133830A1 (fr) * 2019-03-28 2020-10-01 Orionis Biosciences, Inc. Proteines chimeriques basees sur le ligand de la tyrosine kinase-3 de type fms (flt3l)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2069746A1 (fr) * 1990-09-28 1992-03-29 Jonathan I. Rosen Facteurs de croissance heterogenes
US5376367A (en) * 1991-11-22 1994-12-27 Immunex Corporation Fusion proteins comprising MGF and IL-3
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US6057133A (en) * 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
US5635599A (en) * 1994-04-08 1997-06-03 The United States Of America As Represented By The Department Of Health And Human Services Fusion proteins comprising circularly permuted ligands

Similar Documents

Publication Publication Date Title
JP2000502280A5 (fr)
JP2000514806A5 (fr)
JP2000508686A5 (fr)
JP2001508247A5 (fr)
JP2000501771A5 (fr)
JP2000501599A5 (fr)
JP2000507458A5 (fr)
JP2000507453A5 (fr)
JP2002512554A5 (fr)
JP2001502652A5 (fr)
JP2000511583A5 (fr)
JP2001501262A5 (fr)
JP2000513978A5 (fr)
JP2000502472A5 (fr)
JP2000501825A5 (fr)
JP2000500874A5 (fr)
JP2000502485A5 (fr)
JP2000502425A5 (fr)
JP2000501774A5 (fr)
JP2000502570A5 (fr)
JP2000500912A5 (fr)
JP2000502568A5 (fr)
JP2000501876A5 (fr)
JP2002515743A5 (fr)
JP2000501744A5 (fr)